Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

RETRACTED ARTICLE: A two-pronged attack on antibiotic-resistant microbes

Isoprenoid molecules are essential in many disease-causing microorganisms, and intermediates made during their synthesis trigger immune-defence responses by γδ T cells. ‘Immunoantibiotics’ exploit this dual vulnerability.
  1. Youcef Mehellou

    1. Youcef Mehellou is in the School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Benjamin E. Willcox

    1. Benjamin E. Willcox is at the Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

The emergence of strains of harmful microorganisms that are resistant to antibiotic treatment is a major global health concern. This has prompted ongoing drug-development efforts, including the identification of possible biological targets linked to essential microbial processes. However, the clinical development of drugs is slow, and the emergence of resistance to newly developed compounds remains a continuing problem. Finding alternative ways to tackle the emergence of antibiotic-resistant bacteria is of paramount importance. Writing in Nature, Singh et al.1 outline a two-pronged strategy to address this challenge.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 589, 517-518 (2021)

doi: https://doi.org/10.1038/d41586-020-03660-z

Updates & Corrections

  • Retraction 27 September 2021: In view of the fact that the authors of the article ‘IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance’ (K. S. Singh et al. Nature 589, 597–602; 2021) are retracting their report, the authors of this News & Views wish to retract their article, which dealt with this study and was based on the accuracy and reproducibility of the data in the study.

References

  1. Singh, K. S. et al. Nature 589, 597–602 (2021).

    Article  Google Scholar 

  2. Zhao, L., Chang, W.-C., Xiao, Y., Liu, H. W. & Liu, P. Annu. Rev. Biochem. 82, 497–530 (2013).

    Article  PubMed  Google Scholar 

  3. Janthawornpong, K. et al. J. Am. Chem. Soc. 135, 1816–1822 (2013).

    Article  PubMed  Google Scholar 

  4. Jomaa, H. et al. Science 285, 1573–1576 (1999).

    Article  PubMed  Google Scholar 

  5. McAteer, S., Coulson, A., McLennan, N. & Masters, M. J. Bacteriol. 183, 7403–7407 (2001).

    Article  PubMed  Google Scholar 

  6. Wang, K. et al. J. Am. Chem. Soc. 132, 6719–6727 (2010).

    Article  PubMed  Google Scholar 

  7. Zinglé, C., Kuntz, L., Tritsch, D., Grosdemange-Billiard, C. & Rohmer, M. J. Org. Chem. 75, 3203–3207 (2010).

    Article  PubMed  Google Scholar 

  8. Morita, C. T., Jin, C., Sarikonda, G. & Wang, H. Immunol. Rev. 215, 59–76 (2007).

    Article  PubMed  Google Scholar 

  9. Willcox, C. R., Mohammed, F. & Willcox, B. E. Immunol. Rev. 298, 25–46 (2020).

    Article  PubMed  Google Scholar 

  10. Silva-Santos, B., Mensurado, S. & Coffelt, S. B. Nature Rev. Cancer 19, 392–404 (2019).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links